Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis

NCT0709546532 sitesClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Clareo Health | Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis